Freeman Kevin Lee
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Freeman Kevin Lee. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HCAT | Chief Commercial Officer | Tax Withholding | 16,401 | $2.90 | $47,563 | Dec 1, 2025 |
| HCAT | Chief Commercial Officer | Tax Withholding | 4,578 | $3.36 | $15,382 | Sep 2, 2025 |
| HCAT | Chief Commercial Officer | Tax Withholding | 4,747 | $3.63 | $17,232 | Jun 2, 2025 |
| HCAT | Chief Commercial Officer | Tax Withholding | 10,800 | $4.58 | $49,464 | Mar 3, 2025 |
| HCAT | Chief Commercial Officer | Award / Grant | 140,000 | — | — | Feb 20, 2025 |
| HCAT | Chief Commercial Officer | Sale | 7,500 | $8.94 | $67,050 | Dec 1, 2024 |
| HCAT | Chief Commercial Officer | Sale | 7,500 | $7.22 | $54,150 | Sep 3, 2024 |
| HCAT | Chief Commercial Officer | Sale | 7,500 | $6.53 | $48,975 | Jun 11, 2024 |
| HCAT | Chief Commercial Officer | Tax Withholding | 2,951 | $6.53 | $19,270 | Jun 3, 2024 |
| HCAT | Chief Commercial Officer | Tax Withholding | 4,540 | $8.05 | $36,547 | Mar 1, 2024 |
| HCAT | Chief Commercial Officer | Award / Grant | 3,334 | — | — | Feb 20, 2024 |
| HCAT | Chief Commercial Officer | Tax Withholding | 2,921 | $7.45 | $21,761 | Dec 1, 2023 |
| HCAT | Chief Commercial Officer | Tax Withholding | 8,460 | $11.78 | $99,659 | Sep 1, 2023 |
| HCAT | Chief Commercial Officer | Tax Withholding | 1,038 | $11.24 | $11,667 | Jun 1, 2023 |
| HCAT | Chief Commercial Officer | Award / Grant | 1,264 | — | — | Mar 1, 2023 |
| HCAT | Chief Growth Officer | Tax Withholding | 2,446 | $10.65 | $26,050 | Dec 1, 2022 |
| HCAT | Chief Growth Officer | Award / Grant | 120,000 | — | — | Sep 8, 2022 |